Close
ACHEMA MIDDLE EAST 2026

Lilly’s Mirikizumab Superior to Cosentyx in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis

Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the primary and all key...

GSK and CureVac announce strategic mRNA technology collaboration

GlaxoSmithKline plc and CureVac announced the signing of a strategic collaboration agreement for the research, development, manufacturing and commercialisation of up to five mRNA-based...

Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development

Sanofi and The University of Texas MD Anderson Cancer Center announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted...

TREMFYA Approved by U.S. FDA as the First Selective Interleukin Inhibitor for Active Psoriatic Arthritis

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. FDA has approved TREMFYA for adult patients with active psoriatic arthritis (PsA),...

Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab

Catalent and Humanigen, Inc. announced the expansion of their relationship, under which Catalent will provide development, manufacturing and commercialization services for lenzilumab, Humanigen’s proprietary...

Danone Ltd invests €100m in specialized nutrition in China

Danone has announced a series of investments it said will strengthen local market capabilities, support and commitment of its specialized nutrition business in China. The...

Vetter expands its Development Service with new site in Austria

With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...